193954-26-6|Fmoc-β-HoAla-OH| Ambeed

CAS No. :	193954-26-6
Formula :	C₁₉H₁₉NO₄
M.W :	325.36
SMILES Code :	C[C@H](NC(OCC1C2=C(C3=C1C=CC=C3)C=CC=C2)=O)CC(O)=O
MDL No. :	MFCD00270346
InChI Key :	LYMLSPRRJWJJQD-LBPRGKRZSA-N
Pubchem ID :	5706672

Safety of [ 193954-26-6 ]

GHS Pictogram:
Signal Word:	Warning
Hazard Statements:	H315-H319-H335
Precautionary Statements:	P261-P305+P351+P338

Computational Chemistry of [ 193954-26-6 ] Show Less

Physicochemical Properties

Num. heavy atoms	24
Num. arom. heavy atoms	12
Fraction Csp3	0.26
Num. rotatable bonds	7
Num. H-bond acceptors	4.0
Num. H-bond donors	2.0
Molar Refractivity	89.98
TPSA ? Topological Polar Surface Area: Calculated from Ertl P. et al. 2000 J. Med. Chem.	75.63 Å²

Lipophilicity

Log P_o/w (iLOGP)? iLOGP: in-house physics-based method implemented from Daina A et al. 2014 J. Chem. Inf. Model.	2.46
Log P_o/w (XLOGP3)? XLOGP3: Atomistic and knowledge-based method calculated by XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry	2.99
Log P_o/w (WLOGP)? WLOGP: Atomistic method implemented from Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.	3.39
Log P_o/w (MLOGP)? MLOGP: Topological method implemented from Moriguchi I. et al. 1992 Chem. Pharm. Bull. Moriguchi I. et al. 1994 Chem. Pharm. Bull. Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.	2.55
Log P_o/w (SILICOS-IT)? SILICOS-IT: Hybrid fragmental/topological method calculated by FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com	2.92
Consensus Log P_o/w? Consensus Log P_o/w: Average of all five predictions	2.86

Water Solubility

Log S (ESOL):? ESOL: Topological method implemented from Delaney JS. 2004 J. Chem. Inf. Model.	-3.65
Solubility	0.073 mg/ml ; 0.000224 mol/l
Class? Solubility class: Log S scale Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly	Soluble
Log S (Ali)? Ali: Topological method implemented from Ali J. et al. 2012 J. Chem. Inf. Model.	-4.24
Solubility	0.0186 mg/ml ; 0.0000573 mol/l
Class? Solubility class: Log S scale Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly	Moderately soluble
Log S (SILICOS-IT)? SILICOS-IT: Fragmental method calculated by FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com	-5.29
Solubility	0.00166 mg/ml ; 0.00000511 mol/l
Class? Solubility class: Log S scale Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly	Moderately soluble

Pharmacokinetics

GI absorption? Gatrointestinal absorption: according to the white of the BOILED-Egg	High
BBB permeant? BBB permeation: according to the yolk of the BOILED-Egg	Yes
P-gp substrate? P-glycoprotein substrate: SVM model built on 1033 molecules (training set) and tested on 415 molecules (test set) 10-fold CV: ACC=0.72 / AUC=0.77 External: ACC=0.88 / AUC=0.94	Yes
CYP1A2 inhibitor? Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set) and tested on 3000 molecules (test set) 10-fold CV: ACC=0.83 / AUC=0.90 External: ACC=0.84 / AUC=0.91	Yes
CYP2C19 inhibitor? Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set) and tested on 3000 molecules (test set) 10-fold CV: ACC=0.80 / AUC=0.86 External: ACC=0.80 / AUC=0.87	No
CYP2C9 inhibitor? Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set) and tested on 2075 molecules (test set) 10-fold CV: ACC=0.78 / AUC=0.85 External: ACC=0.71 / AUC=0.81	Yes
CYP2D6 inhibitor? Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set) and tested on 1068 molecules (test set) 10-fold CV: ACC=0.79 / AUC=0.85 External: ACC=0.81 / AUC=0.87	No
CYP3A4 inhibitor? Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set) and tested on 2579 molecules (test set) 10-fold CV: ACC=0.77 / AUC=0.85 External: ACC=0.78 / AUC=0.86	No
Log Kp (skin permeation)? Skin permeation: QSPR model implemented from Potts RO and Guy RH. 1992 Pharm. Res.	-6.16 cm/s

Druglikeness

Lipinski? Lipinski (Pfizer) filter: implemented from Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev. MW ≤ 500 MLOGP ≤ 4.15 N or O ≤ 10 NH or OH ≤ 5	0.0
Ghose? Ghose filter: implemented from Ghose AK. et al. 1999 J. Comb. Chem. 160 ≤ MW ≤ 480 -0.4 ≤ WLOGP ≤ 5.6 40 ≤ MR ≤ 130 20 ≤ atoms ≤ 70	None
Veber? Veber (GSK) filter: implemented from Veber DF. et al. 2002 J. Med. Chem. Rotatable bonds ≤ 10 TPSA ≤ 140	0.0
Egan? Egan (Pharmacia) filter: implemented from Egan WJ. et al. 2000 J. Med. Chem. WLOGP ≤ 5.88 TPSA ≤ 131.6	0.0
Muegge? Muegge (Bayer) filter: implemented from Muegge I. et al. 2001 J. Med. Chem. 200 ≤ MW ≤ 600 -2 ≤ XLOGP ≤ 5 TPSA ≤ 150 Num. rings ≤ 7 Num. carbon > 4 Num. heteroatoms > 1 Num. rotatable bonds ≤ 15 H-bond acc. ≤ 10 H-bond don. ≤ 5	0.0
Bioavailability Score? Abbott Bioavailability Score: Probability of F > 10% in rat implemented from Martin YC. 2005 J. Med. Chem.	0.56

Medicinal Chemistry

PAINS? Pan Assay Interference Structures: implemented from Baell JB. & Holloway GA. 2010 J. Med. Chem.	0.0 alert
Brenk? Structural Alert: implemented from Brenk R. et al. 2008 ChemMedChem	0.0 alert: heavy_metal
Leadlikeness? Leadlikeness: implemented from Teague SJ. 1999 Angew. Chem. Int. Ed. 250 ≤ MW ≤ 350 XLOGP ≤ 3.5 Num. rotatable bonds ≤ 7	No; 1 violation:MW<0.0
Synthetic accessibility? Synthetic accessibility score: from 1 (very easy) to 10 (very difficult) based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties, trained on 12'782'590 molecules and tested on 40 external molecules (r² = 0.94)	3.67

Application In Synthesis of [ 193954-26-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

Downstream synthetic route of [ 193954-26-6 ]

[ 193954-26-6 ] Synthesis Path-Downstream 1~54

1
[ 193954-26-6 ]
[ 193887-44-4 ]
[ 346610-79-5 ]
[ 359586-64-4 ]
C₆₇H₁₁₅N₁₇O₁₂ [ No CAS ]

References: [1]Journal of the American Chemical Society,2005,vol. 127,p. 11516 - 11529.

2
[ 193954-26-6 ]
[ 193887-44-4 ]
[ 346610-79-5 ]
[ 359586-64-4 ]
C₆₄H₁₀₉N₁₉O₁₂ [ No CAS ]

References: [1]Journal of the American Chemical Society,2005,vol. 127,p. 11516 - 11529.

3
[ 193954-26-6 ]
[ 203854-51-7 ]
[ 346610-79-5 ]
[ 359586-64-4 ]
Fmoc-β³-L-homoleucine [ No CAS ]
C₆₂H₁₀₄N₁₆O₁₄ [ No CAS ]

References: [1]Journal of the American Chemical Society,2005,vol. 127,p. 11516 - 11529.

4
[ 50-00-0 ]
[ 193954-26-6 ]
(S)-4-methyl-6-oxo-[1,3]oxazinane-3-carboxylic acid 9H-fluoren-9-ylmethyl ester [ No CAS ]

References: [1]Tetrahedron Letters,2006,vol. 47,p. 1691 - 1694.

5
[ 29022-11-5 ]
[ 35661-60-0 ]
[ 71989-23-6 ]
[ 193954-26-6 ]
Fmoc-Thr(t-Bu)-OH [ No CAS ]
Fmoc-Val-OH [ No CAS ]
H-β-HAla-Leu-Gly-Ile-Gly-Ile-Leu-Thr-Val-OH [ No CAS ]

References: [1]Journal of Medicinal Chemistry,2000,vol. 43,p. 3803 - 3808.

6
C₂₀H₂₀N₂O₅ [ No CAS ]
[ 76-05-1 ]
[ 193954-26-6 ]
[ 193954-28-8 ]
Fmoc-β³-HGln-OH [ No CAS ]
H-(S)-β³hLys-(S)-β³hPhe-(S)-β³hAla-(S)-β³hLys-(S)-β³hGln-(S)-β³hAla-(S)-β³hAsn-(S)-β³hAla-(S)-β³hAla-(S)-β³hAsn-(S)-β³hLys-(S)-β³hAla-(S)-β³hAsn-(S)-β³hLys-(S)-β³hPhe-OH trifluoroacetate [ No CAS ]

References: [1]Helvetica Chimica Acta,2006,vol. 89,p. 3087 - 3103.

7
C₂₀H₂₀N₂O₅ [ No CAS ]
[ 193954-26-6 ]
[ 193954-28-8 ]
H-(S)-β³hAla-(S)-β³hAsn-(S)-β³hAla-(S)-β³hAla-(S)-β³hAsn-(S)-β³hAla-(S)-β³hPhe-OH [ No CAS ]

References: [1]Helvetica Chimica Acta,2006,vol. 89,p. 3087 - 3103.

8
[ 172695-33-9 ]
[ 193954-26-6 ]
[ 193954-28-8 ]
(S)-3-(9H-fluoren-9-ylmethoxycarbonylamino)-4-(4-hydroxyphenyl)butyric acid [ No CAS ]
(S)-3-(9H-fluoren-9-ylmethoxycarbonylamino)butyryl-Wang resin [ No CAS ]
C₈₀H₁₃₀FN₁₅O₁₉ [ No CAS ]

References: [1]Helvetica Chimica Acta,2007,vol. 90,p. 2251 - 2273.

9
[ 35661-39-3 ]
Fmoc-Phe-OH [ No CAS ]
[ 193954-26-6 ]

References: [1]Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry,2004,vol. 43,p. 2152 - 2158.

10
[ 193954-26-6 ]
(S)-3-[(9H-fluoren-9-ylmethoxycarbonyl)-methyl-amino]-butyric acid [ No CAS ]

References: [1]Tetrahedron Letters,2006,vol. 47,p. 1691 - 1694.

11
[ 193954-26-6 ]
(2-isocyanato-1-methyl-ethyl)-carbamic acid 9<i>H</i>-fluoren-9-ylmethyl ester [ No CAS ]

References: [1]Helvetica Chimica Acta,2002,vol. 85,p. 3692 - 3711.
[2]Tetrahedron Letters,2000,vol. 41,p. 1553 - 1557.
[3]Tetrahedron Letters,2011,vol. 52,p. 5620 - 5624.

12
[ 193954-26-6 ]
[ 270575-65-0 ]

References: [1]Helvetica Chimica Acta,2002,vol. 85,p. 3692 - 3711.
[2]Tetrahedron Letters,2000,vol. 41,p. 1553 - 1557.
[3]Synlett,2010,p. 1096 - 1100.
[4]Tetrahedron Letters,2011,vol. 52,p. 5620 - 5624.

13
[ 193954-26-6 ]
[ 270575-71-8 ]

References: [1]Helvetica Chimica Acta,2002,vol. 85,p. 3692 - 3711.
[2]Tetrahedron Letters,2000,vol. 41,p. 1553 - 1557.

14
[ 35661-39-3 ]
Fmoc-Arg(mesitylene-2-sulfonyl)-OH, Fmoc-Glu(t-Bu)-OH [ No CAS ]
[ 193954-26-6 ]

References: [1]Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry,1999,vol. 38,p. 418 - 423.

15
[ 35661-39-3 ]
[ 193954-26-6 ]

References: [1]Helvetica Chimica Acta,1998,vol. 81,p. 187 - 206.
[2]Helvetica Chimica Acta,1998,vol. 81,p. 59 - 65.

16
C₂₁H₂₁NO₆ [ No CAS ]
[ 193954-26-6 ]

References: [1]Helvetica Chimica Acta,1998,vol. 81,p. 59 - 65.

17
[ 103321-50-2 ]
[ 193954-26-6 ]

References: [1]Journal of the Chemical Society. Perkin transactions I,1997,p. 1969 - 1971.

18
[ 172695-33-9 ]
[ 193954-26-6 ]
[ 193887-44-4 ]
[ 193954-28-8 ]
[ 209252-17-5 ]
[ 193954-27-7 ]
[ 203854-47-1 ]
Boc-β³-HCys(Trt)-OH [ No CAS ]
CF3CO2H*H2N-β(3)hCys-β(3)hAla-β(3)hLeu-β(3)hLys-β(3)hLeu-β(3)hPhe-β(3)hAsp-β(3)hVal-β(3)hPhe-β(3)hLys-β(3)hAla-β(3)hIle-β(3)hAsp-OH [ No CAS ]

References: [1]Helvetica Chimica Acta,2008,vol. 91,p. 2035 - 2056.

19
C₂₅H₂₈NO₅Pol [ No CAS ]
[ 172695-33-9 ]
[ 193954-26-6 ]
[ 203854-49-3 ]
6-amino-3-(9<i>H</i>-fluoren-9-ylmethoxycarbonylamino)-hexanoic acid [ No CAS ]
[ 1147129-84-7 ]

References: [1]Bioorganic and Medicinal Chemistry,2009,vol. 17,p. 2038 - 2046.

20
[ 1135148-98-9 ]
[ 108-24-7 ]
[ 172695-33-9 ]
[ 193954-26-6 ]
[ 193887-44-4 ]
[ 1188890-05-2 ]

References: [1]Organic Letters,2009,vol. 11,p. 4438 - 4440.

21
[ 1135148-98-9 ]
[ 108-24-7 ]
[ 172695-33-9 ]
[ 193954-26-6 ]
[ 193887-44-4 ]
[ 1188890-10-9 ]

References: [1]Organic Letters,2009,vol. 11,p. 4438 - 4440.

22
[ 1135148-98-9 ]
[ 172695-33-9 ]
[ 193954-26-6 ]
(R)-3-(9H-Fluoren-9-ylmethoxycarbonylamino)-4-methyl-hexanoic acid [ No CAS ]
[ 193887-44-4 ]
C₃₆H₆₄N₆O₉ [ No CAS ]

References: [1]Organic Letters,2009,vol. 11,p. 4438 - 4440.

23
[ 1135148-98-9 ]
[ 172695-33-9 ]
[ 193954-26-6 ]
(R)-3-(9H-Fluoren-9-ylmethoxycarbonylamino)-4-methyl-hexanoic acid [ No CAS ]
[ 193887-44-4 ]
C₃₈H₆₈N₆O₉ [ No CAS ]

References: [1]Organic Letters,2009,vol. 11,p. 4438 - 4440.

24
[ 1135148-98-9 ]
[ 172695-33-9 ]
[ 193954-26-6 ]
[ 193887-44-4 ]
(S)-3-(9H-fluoren-9-ylmethoxycarbonylamino)-4-(4-hydroxyphenyl)butyric acid [ No CAS ]
[ 1188890-03-0 ]

References: [1]Organic Letters,2009,vol. 11,p. 4438 - 4440.

25
[ 1135148-98-9 ]
[ 172695-33-9 ]
[ 193954-26-6 ]
[ 193887-44-4 ]
(S)-3-(9H-fluoren-9-ylmethoxycarbonylamino)-4-(4-hydroxyphenyl)butyric acid [ No CAS ]
[ 1188890-08-5 ]

References: [1]Organic Letters,2009,vol. 11,p. 4438 - 4440.

26
[ 882847-34-9 ]
[ 172695-33-9 ]
[ 193954-26-6 ]
[ 193954-27-7 ]
[ 203854-51-7 ]
[ 203854-47-1 ]
[ 219967-69-8 ]
[ 1207335-59-8 ]

References: [1]Helvetica Chimica Acta,2009,vol. 92,p. 2698 - 2721.

27
[ 125686-90-0 ]
[ 172695-33-9 ]
[ 193954-26-6 ]
[ 193887-44-4 ]
[ 209252-17-5 ]
[ 193954-27-7 ]
[ 203854-51-7 ]
[ 203854-49-3 ]
[ 203854-47-1 ]
[ 1207335-44-1 ]

References: [1]Helvetica Chimica Acta,2009,vol. 92,p. 2698 - 2721.

28
[ 108-24-7 ]
[ 172695-33-9 ]
[ 193954-26-6 ]
[ 193954-27-7 ]
[ 203854-51-7 ]
[ 203854-47-1 ]
[ 219967-69-8 ]
[ 1207335-57-6 ]

References: [1]Helvetica Chimica Acta,2009,vol. 92,p. 2698 - 2721.

29
[ 35661-38-2 ]
[ 35661-60-0 ]
[ 86123-10-6 ]
[ 35737-15-6 ]
[ 94744-50-0 ]
[ 172695-33-9 ]
[ 193954-26-6 ]
[ 193887-44-4 ]
[ 193954-27-7 ]
[ 203854-49-3 ]
[ 203854-47-1 ]
N-FMOC-O-tert-butyl-D-threonine [ No CAS ]
H-(R)-β³hVal-(S)-β³hGlu-(S)-β³hLeu-(S)-β³hAla-(S)-β³hLys-(R)-β³hIle-(R)-Phe-(R)-Ser-(R)-Leu-Aib-(R)-Trp-(R)-Thr-(R)-Ala-NH2 [ No CAS ]

References: [1]Helvetica Chimica Acta,2009,vol. 92,p. 2698 - 2721.

30
[ 172695-33-9 ]
[ 193954-26-6 ]
[ 193954-27-7 ]
[ 203854-51-7 ]
[ 203854-47-1 ]
[ 219967-69-8 ]
[ 1207335-42-9 ]

References: [1]Helvetica Chimica Acta,2009,vol. 92,p. 2698 - 2721.

31
[ 104-03-0 ]
[ 170852-97-8 ]
[ 79-30-1 ]
[ 146803-44-3 ]
[ 154524-72-8 ]
[ 645-45-4 ]
[ 193954-26-6 ]
C₇₈H₉₉N₉O₁₀ [ No CAS ]